Foresite Capital Management V, LLC - 05 Apr 2023 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role: 10%+ Owner
Signature: /s/ Dennis Ryan, on behalf of Foresite Capital Management V, LLC
Issuer symbol: N/A
Transactions as of: 05 Apr 2023
Net transactions value: +$1,160,928
Form type: 4
Filing time: 06 Apr 2023, 21:08:12 UTC
Previous filing: 03 Jan 2023
Next filing: 19 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRDS	Common Stock	Purchase	$1,160,928	+773,952	+6%	$1.50	13,583,762	05 Apr 2023	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 5, 2023, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Content

On April 5, 2023, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.